Maravai LifeSciences Holdings Inc. has announced a change in its certifying accountants, appointing Deloitte & Touche LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision, approved by the company's Audit Committee, follows the dismissal of Ernst & Young LLP. During the fiscal years 2023 and 2024, Ernst & Young reported material weaknesses in Maravai's internal control over financial reporting, particularly concerning revenue, accounts receivable, and goodwill impairment. These issues were outlined in Maravai's 2024 annual report. The Audit Committee has ensured that Deloitte is fully informed about these weaknesses to facilitate a smooth transition.